| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.03 |